APA (7th ed.) Citation

Tu, B., Zhang, H., Chen, L., Yang, R., Liu, P., Li, R., & Qiao, J. (2024). Co-administration of GnRH-agonist and hCG (double trigger) for final oocyte maturation increases the number of top-quality embryos in patients undergoing IVF/ICSI cycles. Journal of Ovarian Research, 17(1), 1. https://doi.org/10.1186/s13048-024-01465-6

Chicago Style (17th ed.) Citation

Tu, Binbin, Hua Zhang, Lixue Chen, Rui Yang, Ping Liu, Rong Li, and Jie Qiao. "Co-administration of GnRH-agonist and HCG (double Trigger) for Final Oocyte Maturation Increases the Number of Top-quality Embryos in Patients Undergoing IVF/ICSI Cycles." Journal of Ovarian Research 17, no. 1 (2024): 1. https://doi.org/10.1186/s13048-024-01465-6.

MLA (9th ed.) Citation

Tu, Binbin, et al. "Co-administration of GnRH-agonist and HCG (double Trigger) for Final Oocyte Maturation Increases the Number of Top-quality Embryos in Patients Undergoing IVF/ICSI Cycles." Journal of Ovarian Research, vol. 17, no. 1, 2024, p. 1, https://doi.org/10.1186/s13048-024-01465-6.